Informationen:
Fehler:
ID
31699
Beschreibung
Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01417390
Link
https://clinicaltrials.gov/show/NCT01417390
Stichworte
Versionen (2)
- 21.09.18 21.09.18 -
- 21.09.18 21.09.18 - Sarah Riepenhausen
Rechteinhaber
First People's Hospital of Foshan
Hochgeladen am
21. September 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Nasopharyngeal Carcinoma NCT01417390
Eligibility Nasopharyngeal Carcinoma NCT01417390
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Nasopharyngeal Carcinoma NCT01417390
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Non-keratinizing nasopharyngeal carcinome
Item
patients with newly histologically confirmed non-keratinizing (according to world health organization (who 2005) histologically type).
boolean
C1334926 (UMLS CUI [1,1])
C1301142 (UMLS CUI [1,2])
C1301142 (UMLS CUI [1,2])
Karnofsky Status
Item
karnofsky scale (kps) > 70.
boolean
C0206065 (UMLS CUI [1])
AJCC Stage
Item
tumor staged is according to the 7th american joint commission on cancer edition as stage iii：t1-2n2m0, t3n0-2m0 stage iva：t4n0-2m0 stage ivb：any t、n3.
boolean
C0441915 (UMLS CUI [1])
Leucocyte count, hemoglobin, platelet count
Item
adequate marrow: leucocyte count ≥4000/μl, hemoglobin ≥90g/l and platelet count ≥100000/μl.
boolean
C0023508 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
C0032181 (UMLS CUI [4])
ALT, AST, Alkaline Phosphatase, Bilirubin
Item
normal liver function test: alanine aminotransferase (alt)、aspartate aminotransferase (ast) <1.5×upper limit of normal (uln) concomitant with alkaline phosphatase (alp) ≤2.5×uln, and bilirubin ≤uln.
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201850 (UMLS CUI [3])
C0201913 (UMLS CUI [4])
C0201899 (UMLS CUI [2])
C0201850 (UMLS CUI [3])
C0201913 (UMLS CUI [4])
Creatinine clearance
Item
adequate renal function: creatinine clearance ≥60 ml/min.
boolean
C0373595 (UMLS CUI [1])
Informed consent
Item
patients must be informed of the investigational nature of this study and give written informed consent.
boolean
C0021430 (UMLS CUI [1])
Squamous cell carcinoma
Item
who type keratinizing squamous cell carcinoma.
boolean
C0007137 (UMLS CUI [1])
Age
Item
age >60 years or <18 years.
boolean
C0001779 (UMLS CUI [1])
Palliative intent
Item
treatment with palliative intent.
boolean
C1285530 (UMLS CUI [1])
Pregnancy or lactation
Item
pregnancy or lactation.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Prior treatment
Item
prior radiotherapy, chemotherapy or surgery (except diagnostic) to primary tumor or nodes.
boolean
C1514463 (UMLS CUI [1])
Comorbidity, including heart disease, chronic hepatitis, renal disease, diabetes and emotional disturbance
Item
any severe intercurrent disease including unstable cardiac disease, chronic hepatitis, renal disease, diabetes with poor control, and emotional disturbance.
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0018799 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0019189 (UMLS CUI [3])
C0022658 (UMLS CUI [4])
C0011849 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
C0013985 (UMLS CUI [6])
C0205082 (UMLS CUI [1,2])
C0018799 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0019189 (UMLS CUI [3])
C0022658 (UMLS CUI [4])
C0011849 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
C0013985 (UMLS CUI [6])